Income Taxes (Tables)
|
12 Months Ended |
Jul. 31, 2026 |
| Income Tax Disclosure [Abstract] |
|
| Income before provision for income taxes |
Loss from continuing operations before income taxes consists of the following: | | | | | | | | | | | | | | | | | Fiscal Years Ended July 31, | | | 2026 | | 2025 | | U.S. | | $ | (14,470,000) | | | (19,347,000) | | | Foreign | | (2,964,000) | | | 71,000 | | | | $ | (17,434,000) | | | (19,276,000) | |
|
| Provision for income taxes |
The provision for (benefit from) income taxes included in the accompanying Consolidated Statements of Operations consists of the following: | | | | | | | | | | | | | | | | | Fiscal Years Ended July 31, | | | 2026 | | 2025 | | Federal – current | | $ | 44,000 | | | 673,000 | | | Federal – deferred | | — | | | — | | | | | | | | State and local – current | | (88,000) | | | 371,000 | | | State and local – deferred | | — | | | — | | | | | | | | Foreign – current | | (141,000) | | | (136,000) | | | Foreign – deferred | | 1,032,000 | | | (1,187,000) | | | Provision for (benefit from) income taxes | | $ | 847,000 | | | (279,000) | |
|
| Provision for income taxes differed from amounts computed by applying the U.S. Federal income tax rate |
Income taxes differed from the amounts computed by applying the U.S. Federal income tax rate as a result of the following: | | | | | | | | | | | | | | | | | Fiscal Year Ended July 31, 2026 | | | Amount | | Rate | Loss from continuing operations before income taxes | | $ | (17,434,000) | | | | | | | | | | U.S. Federal statutory income tax rate (computed "expected" tax benefit) | | (3,661,000) | | | 21.0 | % | | | | | | | Nontaxable or nondeductible items: | | | | | | Revaluation of warrants and embedded derivatives | | (4,639,000) | | | 26.6 | | | Compensation | | 686,000 | | | (3.9) | | | Other | | (93,000) | | | 0.5 | | | Effect of cross border tax laws: | | | | | | Global Intangible Low Taxed Income ("GILTI") | | 1,148,000 | | | (6.6) | | | Change in valuation allowance | | 5,936,000 | | | (34.0) | | State and local income taxes (net of Federal benefit) (1) | | (84,000) | | | 0.5 | | | Other | | (28,000) | | | 0.2 | | | Foreign tax effects: | | | | | | Canada | | | | | | Change in valuation allowance | | 1,718,000 | | | (9.9) | | | Other | | (4,000) | | | — | | | Other foreign jurisdictions | | 35,000 | | | (0.2) | | | Changes in unrecognized tax benefits | | (167,000) | | | 0.9 | | | Provision for income taxes | | $ | 847,000 | | | (4.9) | % |
(1) The jurisdictions that comprise the majority of the domestic state and local income taxes is Texas and Pennsylvania.
| | | | | | | | | | | | | | | | | Fiscal Year Ended July 31, 2025 | | | Amount | | Rate | Loss from continuing operations before income taxes | | $ | (19,276,000) | | | | | | | | | | U.S. Federal statutory income tax rate (computed "expected" tax benefit) | | $ | (4,048,000) | | | 21.0 | % | | Increase (reduction) in income taxes due to: | | | | | | State and local income taxes, net of valuation allowance and Federal benefit | | 371,000 | | | (1.9) | | | Stock-based compensation | | 931,000 | | | (4.8) | | | Research and experimentation credits | | (374,000) | | | 1.9 | | | | | | | | | | | | | Revaluation of warrants and embedded derivatives | | (8,085,000) | | | 41.9 | | | Nondeductible executive compensation | | 102,000 | | | (0.5) | | | | | | | | | | | | | Change in U.S. Federal and foreign valuation allowances | | 9,936,000 | | | (51.5) | | | | | | | | Foreign income tax rate differential | | 7,000 | | | — | | | Goodwill impairment | | 1,114,000 | | | (5.8) | | | Other, net | | (233,000) | | | 1.2 | | | Benefit from income taxes | | $ | (279,000) | | | 1.5 | % |
|
| Tax effects of temporary differences |
The tax effects of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at July 31, 2026 and 2025 are presented below: | | | | | | | | | | | | | | | | | 2026 | | 2025 | | Deferred tax assets: | | | | | | Inventory and contract reserves | | $ | 339,000 | | | 347,000 | | | Compensation and commissions | | 3,420,000 | | | 3,408,000 | | | Federal, state and foreign research and experimentation credits | | 8,770,000 | | | 7,598,000 | | | Capitalized U.S. research and experimental expenditures | | 2,240,000 | | | 7,029,000 | | | Stock-based compensation | | 1,735,000 | | | 1,656,000 | | | Foreign scientific research and experimental development expenditures | | 2,014,000 | | | 2,006,000 | | | Federal, state and foreign net operating losses | | 6,364,000 | | | 5,367,000 | | | Federal and state capital losses | | — | | | 14,473,000 | | | Lease liabilities | | 3,318,000 | | | 3,286,000 | | | Deferred revenue, non-current | | 2,834,000 | | | 3,371,000 | | | Interest expense limitation | | 23,768,000 | | | 13,411,000 | | | Other | | 2,240,000 | | | 2,098,000 | | | Less: valuation allowance | | (24,134,000) | | | (29,102,000) | | | Total deferred tax assets, net | | 32,908,000 | | | 34,948,000 | | | Deferred tax liabilities: | | | | | | Plant and equipment | | (2,350,000) | | | (2,009,000) | | | Lease right-of-use assets | | (2,707,000) | | | (2,584,000) | | | Intangibles | | (27,633,000) | | | (29,106,000) | | | Total deferred tax liabilities | | (32,690,000) | | | (33,699,000) | | | Net deferred tax assets | | $ | 218,000 | | | 1,249,000 | |
|
| Summary of unrecognized tax benefits |
The following table summarizes the activity related to our unrecognized tax benefits for fiscal years 2026 and 2025 (excluding interest): | | | | | | | | | | | | | | | | | 2026 | | 2025 | | Balance at beginning of period | | $ | 3,875,000 | | | 4,267,000 | | | Increase related to current period | | 34,000 | | | 66,000 | | | Increase related to prior periods | | 63,000 | | | 8,000 | | | Expiration of statute of limitations | | (128,000) | | | (458,000) | | | Decrease related to prior periods | | (77,000) | | | (8,000) | | | Balance at end of period | | $ | 3,767,000 | | | 3,875,000 | |
|
| Schedule of cash paid for income taxes |
During fiscal 2026, net cash paid (received) related to income taxes, by taxing jurisdiction, for continuing operations was as follows:
| | | | | | | | | | Federal: | | | | State: | | | | California | | $ | (54,000) | | | Connecticut | | (129,000) | | | Pennsylvania | | 124,000 | | | Texas | | 85,000 | | | Virginia | | (78,000) | | | Other | | (121,000) | | | Foreign: | | | | Australia | | 60,000 | | | | | | Russia | | (149,000) | | | Total | | $ | (262,000) | |
|